SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Writing Positively About Their Experience Benefits Men With Testicular Cancer, Baylor University Study
September 16, 2011
 · 
1 min read
Lone Star Bio
Mutant Protein May Improve Breast Tumors’ Response To Cancer Drugs, University of Texas MD Anderson Cancer Center Study
September 14, 2011
 · 
1 min read
Lone Star Bio
University of Houston Researchers Work To Develop Screening Method For Superbug
September 9, 2011
 · 
1 min read
Lone Star Bio
Nanocables Light Way to the Future, Rice University Study
September 8, 2011
 · 
1 min read
Lone Star Bio
BRCA1 Gene Mutation Associated With Neoadjuvant Chemotherapy, University of Texas Study
September 8, 2011
 · 
1 min read
Lone Star Bio
Bone Marrow Stem Cell Therapy Safe for Acute Stroke, University of Texas Medical School Study
September 1, 2011
 · 
1 min read
Lone Star Bio
Tiny Wires Change Behavior at Nanoscale, Rice University Study
August 30, 2011
 · 
1 min read
Lone Star Bio
No Major Heart Risk Seen in New Psoriasis Drugs, Baylor Research Institute Study
August 24, 2011
 · 
1 min read
Lone Star Bio
Nano Bundles Pack a Powerful Punch, Rice University Study
August 23, 2011
 · 
1 min read
Lone Star Bio
Researchers Explore Treatments for Breast and Colon Cancers, University of Houston Study
August 23, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
January 6, 2026
 · 
1 min read
Press Releases
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
January 6, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
January 6, 2026
 · 
7 min read
Press Releases
OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate
January 6, 2026
 · 
1 min read
Press Releases
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
January 6, 2026
 · 
10 min read
Press Releases
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
January 6, 2026
 · 
2 min read
Press Releases
Vizient Analysis Reveals Early and Varied Drug Pricing Shifts Following Enactment of the Inflation Reduction Act
January 6, 2026
 · 
3 min read
Press Releases
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
January 6, 2026
 · 
6 min read
Press Releases
TYBR Health Announces First U.S. Clinical Use of the B3 GEL™ System
January 6, 2026
 · 
3 min read
Press Releases
Enovis Appoints Oliver Engert as Chief Administrative Officer
January 6, 2026
 · 
1 min read
Load More